Improving flu vaccines: Matrix 2 protein as a possible Influenza A vaccine component

The 2009 “swine flu” H1N1 Influenza A virus pandemic demonstrated the need for influenza vaccines providing broad coverage across multiple strains and subtypes. Current vaccine preparation methods are problematic because they function by inducing antibodies to the highly variable surface glycoproteins of the Influenza A virus, hemagglutinin (HA) and neuraminidase. Because these proteins are susceptible [...]


Category: Infectious disease